Standardized Patient-Centered Medication Review in Home Hospice

NCT03972163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2025-05-21

Study results available
· View outcomes & findings →

Summary

This is a pilot cluster randomized trial that tests the effect of a novel intervention that trains hospice staff to 1. regularly review, simplify, and align patients' prescribed medications with their goals of care as their illness progresses, and 2. support family caregivers with education that empowers them to understand each medication's use, develop skills for safe administration, and 3. understand when stopping medications may be beneficial.

Conditions

  • Hospices
  • Poly Pharmacy
  • Deprescriptions
  • Caregivers
  • Palliative Care
  • Prescription Drug Overuse
  • Interdisciplinary Communication

Interventions

BEHAVIORAL

NIA Medication Management - Active Comparator

As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.

BEHAVIORAL

STOPPFrail (Screening Tool of Older Persons Prescriptions)

A screening tool used by clinicians with frail older adults with life-limiting illness to review medications

BEHAVIORAL

"Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing"

Education resoruce used by clinicians to simplify and align medications with goals of care

BEHAVIORAL

"Key Approaches to Support Informal Family Caregivers in Managing Medications"

Education resource used by clinicians to support Family Care Givers (FCGs)

Sponsors & Collaborators

  • University of Utah

    collaborator OTHER
  • Boston College

    collaborator OTHER
  • National Institute on Aging (NIA)

    collaborator NIH
  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Jennifer Tjia, MD, MSCE · UMass Medical School

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-15
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03972163 on ClinicalTrials.gov